281
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Retrospective Analysis of Azithromycin-Resistant Ureaplasma urealyticum and Mycoplasma hominis Cervical Infection Among Pregnant Women

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 3541-3549 | Received 18 Jan 2023, Accepted 31 May 2023, Published online: 05 Jun 2023

References

  • Dai L, Chaohui L. Consensus on the diagnosis and treatment of mycoplasma infection in genital tract. Chin J Hum Sex. 2016;25(3):80–82. doi:10.3969/j.issn.1672-1993.2016.03.026
  • Plummer EL, Vodstrcil LA, Bodiyabadu K, et al. Are Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum associated with specific genital symptoms and clinical signs in nonpregnant women. Clin Infect Dis. 2021;73(4):659–668. doi:10.1093/cid/ciab061
  • Soni S, Horner P, Rayment M, et al. British association for sexual health and HIV national guideline for the management of infection with mycoplasma genitalium (2018). Int J STD AIDS. 2019;30(10):938–950. doi:10.1177/0956462419825948
  • Oliveira CNT, Oliveira MTS, Oliveira HBM, et al. Association of spontaneous abortion and Ureaplasma parvum detected in placental tissue. Epidemiol Infect. 2020;148:e126. doi:10.1017/S0950268820001302
  • Luton D, Ville Y, Luton-Sigy A, et al. Prevalence and influence of Mycoplasma hominis and Ureaplasma urealyticum in 218 African pregnant women and their infants. Eur J Obstet Gynecol Reprod Biol. 1994;56(2):95–101. doi:10.1016/0028-2243(94)90263-1
  • Farhadifar F, Khodabandehloo M, Ramazanzadeh R, et al. Survey on association between Mycoplasma hominis endocervical infection and spontaneous abortion using polymerase chain reaction. Int J Reprod Biomed. 2016;14(3):181–186.
  • Taylor-Robinson D. The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):425–438. doi:10.1016/j.bpobgyn.2007.01.011
  • Donders GGG, Ruban K, Bellen G, et al. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen. J Perinat Med. 2017;45(5):505–515. doi:10.1515/jpm-2016-0111
  • Ma C, Du J, Dou Y, et al. The associations of genital mycoplasmas with female infertility and adverse pregnancy outcomes: a systematic review and meta-analysis. Reprod Sci. 2021;28(11):3013–3031. doi:10.1007/s43032-020-00399-w
  • Jonduo ME, Vallely LM, Wand H, et al. Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum: a systematic review and meta-analysis. BMJ Open. 2022;12(8):e062990. doi:10.1136/bmjopen-2022-062990
  • Jensen JS, Cusini M, Gomberg M, et al. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30(10):1650–1656. doi:10.1111/jdv.13849
  • Machalek DA, Tao Y, Shilling H, et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20(11):1302–1314. doi:10.1016/S1473-3099(20)30154-7
  • Zhang Y, Fan DS, Fan LJ, et al. Detection and drug resistance of Mycoplasma in 850 patients with genitourinary system infection. Eval Anal Drug Use Hosp China. 2021;21(5):620–623. doi:10.14009/j.issn.1672-2124.2021.05.025
  • Leli C, Mencacci A, Latino MA, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect. 2018;51(2):220–225. doi:10.1016/j.jmii.2017.05.004
  • Laumen JGE, van Alphen LB, Maduna LD, et al. Molecular epidemiological analysis of Mycoplasma genitalium shows low prevalence of azithromycin resistance and a well-established epidemic in South Africa. Sex Transm Infect. 2021;97(2):152–156. doi:10.1136/sextrans-2019-054371
  • Bakheit AH, Al-Hadiya BM, Abd-Elgalil AA. Azithromycin. Profiles Drug Subst Excip Relat Methodol. 2014;39:1–40. doi:10.1016/B978-0-12-800173-8.00001-5
  • de Salazar A, Barrientos-Durán A, Espadafor B, et al. Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018–2019. Sex Transm Infect. 2021;97(1):8–10. doi:10.1136/sextrans-2019-054386
  • Vouga M, Greub G, Prod’hom G, et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect. 2014;20(10):1074–1079. doi:10.1111/1469-0691.12686
  • Khalil A, Prasad S. Screening and prevention of preterm birth in twin pregnancies. Best Pract Res Clin Obstet Gynaecol. 2022;84:179–193. doi:10.1016/j.bpobgyn.2022.08.008
  • Yang Y, Yang JY, Du YL, et al. The survey of the correlation between adverse pregnancy outcomes of women and their menstrual history and birth history in Baoshan city of Yunnan Province. Chin J Fam Plann. 2020;28(9):1342–1345. doi:10.3969/j.issn.1004-8189.2020.09.003
  • Furneri PM, Rappazzo G, Musumarra MP, et al. Genetic basis of natural resistance to erythromycin in Mycoplasma hominis. J Antimicrob Chemother. 2000;45(4):547–548. doi:10.1093/jac/45.4.547
  • Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18(4):757–789. doi:10.1128/CMR.18.4.757-789.2005
  • Bookstaver PB, Bland CM, Griffin B, et al. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35(11):1052–1062. doi:10.1002/phar.1649